KRON

KRONOS BIO INC

Vol
Inst. Holders1 funds
Inst. Value$16.1K
Inst. Activity0 buys / 2 sells

Recent Activity

Inst.
PRUDENTIAL FINANCIAL INC — TRIM
35,400 shares ($29.2K)
Inst.
BANK OF AMERICA CORP — NEAR_EXIT
368 shares ($304.00)

Analyst Ratings

Historical distribution86% buy · 7 analysts · no recent coverage
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell

Top Institutional Holders

FundValueMove
BARCLAYS PLC$16.1K
1 institutional holders with $16.1K total value (16,128 shares) as of 2025-Q3. Top holders: BARCLAYS.

Top Institutional Holders — 2025-Q3

#FundSharesValue% of TrackedLast Move
1BARCLAYS PLC16,128$16.1K100.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
PRUDENTIAL FINANCIAL INCTRIM55,80035,400-36.6%$29.2K2025-Q1
BANK OF AMERICA CORP /DE/NEAR_EXIT3,222368-88.6%$304.002025-Q1
NATIONAL BANK OF CANADA /FI/ADD20,00025,000+25.0%$23.8K2024-Q4
CITADEL ADVISORS LLCTRIM227,86187,201-61.7%$87.2K2024-Q3
NATIONAL BANK OF CANADA /FI/ADD15,00020,000+33.3%$20.0K2024-Q3
BANK OF AMERICA CORP /DE/TRIM6,1233,533-42.3%$3.5K2024-Q3

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 20252410086%
Apr 1, 20252410086%
Mar 1, 20252410086%
Feb 1, 20252410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.